Min Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Min Bai has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
Mengya Liu
Ningxia Medical University Yinchuan Ningxia China
4 shared publicationsYongqiang Duan
Ningxia Medical University Yinchuan Ningxia China
3 shared publicationsShunyi Li
Gansu University of Chinese Medicine Lanzhou Gansu China
2 shared publicationsXutong Jia
Ningxia Medical University Yinchuan Ningxia China
2 shared publicationsYarong Li
College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, 750004, China; Ningxia Key Laboratory of Modernization of Minority Medicine, Yinchuan, 750004, China
2 shared publicationsYonglin Liang
Gansu University of Chinese Medicine Lanzhou Gansu China
2 shared publications
Latest Publications
- Open Access
- 7 October 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (10)
Metabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway
Objective: This study aimed to examine the potential neuroprotective effects of SXZ on cognitive impairment in naturally aging rats and to explore the underlying molecular mechanisms. Methods: Eighteen‐month‐old Sprague–Dawley rats were used as a natural aging model and administered Shenxian Zhou (SXZ) for 6 months. Cognitive function was assessed using behavioral evaluations. Hematoxylin–eosin, Nissl, and immunofluorescence staining for NeuN were performed to evaluate neuronal pathology in aging rats. Metabolomics analysis was performed to characterize hippocampal metabolites, followed by molecular validation. Results: SXZ attenuated age‐related cognitive decline and reduced hippocampal pathological and neuronal damage in naturally aging rats. SXZ‐H significantly modulated glutathione metabolism and ferroptosis‐associated signaling pathways. Transmission electron microscopy revealed mitochondrial morphological changes consistent with ferroptosis in hippocampal neurons of naturally aging rats. Molecular biology experiments further indicated that, subsequent to SXZ‐H intervention, lipid peroxidation and oxidative stress levels were significantly reduced. Furthermore, expression levels of p53 and Keap1 genes and proteins were significantly downregulated, whereas the expression of SLC7A11, GPX4, Nrf2, and HO‐1 genes and proteins was notably upregulated. Conclusion: SXZ‐H effectively mitigates cognitive impairment in naturally aging rats, an effect that may be mediated by promoting glutathione metabolism and regulating key ferroptosis‐related proteins, thereby inhibiting neuronal ferroptosis.
- 7 October 2026
- Published by Wiley in CNS Neuroscience & Therapeutics
- Vol. 32 (10)
Open AccessMetabolomics Analysis Revealed That SXZ Ameliorates Cognitive Impairment in Naturally Aged Rats by Promoting Glutathione Metabolism and Inhibiting the Ferroptosis Pathway
Objective: This study aimed to examine the potential neuroprotective effects of SXZ on cognitive impairment in naturally aging rats and to explore the underlying molecular mechanisms. Methods: Eighteen‐month‐old Sprague–Dawley rats were used as a natural aging model and administered Shenxian Zhou (SXZ) for 6 months. Cognitive function was assessed using behavioral evaluations. Hematoxylin–eosin, Nissl, and immunofluorescence staining for NeuN were performed to evaluate neuronal pathology in aging rats. Metabolomics analysis was performed to characterize hippocampal metabolites, followed by molecular validation. Results: SXZ attenuated age‐related cognitive decline and reduced hippocampal pathological and neuronal damage in naturally aging rats. SXZ‐H significantly modulated glutathione metabolism and ferroptosis‐associated signaling pathways. Transmission electron microscopy revealed mitochondrial morphological changes consistent with ferroptosis in hippocampal neurons of naturally aging rats. Molecular biology experiments further indicated that, subsequent to SXZ‐H intervention, lipid peroxidation and oxidative stress levels were significantly reduced. Furthermore, expression levels of p53 and Keap1 genes and proteins were significantly downregulated, whereas the expression of SLC7A11, GPX4, Nrf2, and HO‐1 genes and proteins was notably upregulated. Conclusion: SXZ‐H effectively mitigates cognitive impairment in naturally aging rats, an effect that may be mediated by promoting glutathione metabolism and regulating key ferroptosis‐related proteins, thereby inhibiting neuronal ferroptosis.
- 1 April 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 366, 121584
Transcriptomic analysis reveals the critical role and mechanisms of Shenxian zhou in preventing age-related cognitive impairment
- 1 April 2026
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 366, 121584
Transcriptomic analysis reveals the critical role and mechanisms of Shenxian zhou in preventing age-related cognitive impairment
- 10 June 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 1) , 116715
Deciphering the function of Xiangsha-Liujunzi-Tang in enhancing duodenal mucosal barrier by inhibiting MC/Tryptase/PAR-2 signaling pathway in functional dyspepsia rats
- 10 June 2023
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 319 (Pt 1) , 116715
Deciphering the function of Xiangsha-Liujunzi-Tang in enhancing duodenal mucosal barrier by inhibiting MC/Tryptase/PAR-2 signaling pathway in functional dyspepsia rats
- 1 December 2015
- Published by Pleiades Publishing Ltd in Journal of Structural Chemistry
- Vol. 56 (7) , 1268-1274
QSAR study of peptide drugs by 3D-HoVAIF
By applying a three-dimensional holographic vector of the atomic interaction field (3D-HoVAIF) to express the structure of three classical peptide drugs, quantitative structure activity relationship...
- 1 December 2015
- Published by Pleiades Publishing Ltd in Journal of Structural Chemistry
- Vol. 56 (7) , 1268-1274
QSAR study of peptide drugs by 3D-HoVAIF
By applying a three-dimensional holographic vector of the atomic interaction field (3D-HoVAIF) to express the structure of three classical peptide drugs, quantitative structure activity relationship...
- 6 December 2013
- Published by Wiley in Biomedical Chromatography
- Vol. 28 (5) , 717-724
Simultaneous determination of corosolic acid and euscaphic acid in the plasma of normal and diabetic rat after oral administration of extract of Potentilla discolor Bunge by high‐performance liquid chromatography/electrospray ionization mass spectrometry
Potentilla discolor Bunge has been used for diabetes in China for a long time. Corosolic acid (CA) and euscaphic acid (EA), with significant anti‐diabetic activity, are two major triterpenoids in P. discolor. In this study, a specific, sensitive and convenient LC‐MS method has been developed for simultaneous determination of CA and EA in the plasma of normal and diabetic rats after oral administration of the extract of P. discolor. The chromatographic separation was achieved using an Alltima C18 column (53 × 7.0 mm, i.d., 3 µm) with a mobile phase composed of 0.1% formic acid water and 0.1% formic acid acetonitrile at a flow rate of 1.0 mL/min. The detection was performed by MS with electrospray ionization interface in negative selected ion monitoring mode. All the validation data, such as specificity, linearity (r2 > 0.9991 within 0.025–10.0 µg/mL), lower limit of quantitation (2.5 ng/mL), precision (intra‐ and inter‐day <14.7%), accuracy (<15.0%), recovery (85.7–110.8%) and stability were determined and all of them were within the required limits. This method was successfully applied for the evaluation of the pharmacokinetic behaviors of these two compounds in the plasma of normal and diabetic rats. Copyright © 2013 John Wiley & Sons, Ltd.
- 6 December 2013
- Published by Wiley in Biomedical Chromatography
- Vol. 28 (5) , 717-724
Simultaneous determination of corosolic acid and euscaphic acid in the plasma of normal and diabetic rat after oral administration of extract of Potentilla discolor Bunge by high‐performance liquid chromatography/electrospray ionization mass spectrometry
Potentilla discolor Bunge has been used for diabetes in China for a long time. Corosolic acid (CA) and euscaphic acid (EA), with significant anti‐diabetic activity, are two major triterpenoids in P. discolor. In this study, a specific, sensitive and convenient LC‐MS method has been developed for simultaneous determination of CA and EA in the plasma of normal and diabetic rats after oral administration of the extract of P. discolor. The chromatographic separation was achieved using an Alltima C18 column (53 × 7.0 mm, i.d., 3 µm) with a mobile phase composed of 0.1% formic acid water and 0.1% formic acid acetonitrile at a flow rate of 1.0 mL/min. The detection was performed by MS with electrospray ionization interface in negative selected ion monitoring mode. All the validation data, such as specificity, linearity (r2 > 0.9991 within 0.025–10.0 µg/mL), lower limit of quantitation (2.5 ng/mL), precision (intra‐ and inter‐day <14.7%), accuracy (<15.0%), recovery (85.7–110.8%) and stability were determined and all of them were within the required limits. This method was successfully applied for the evaluation of the pharmacokinetic behaviors of these two compounds in the plasma of normal and diabetic rats. Copyright © 2013 John Wiley & Sons, Ltd.
- 25 January 2012
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 62 (03) , 138-144
Determination of the Plasma Pharmacokinetic and Tissue Distributions of Swertiamarin in Rats by Liquid Chromatography with Tandem Mass Spectrometry
An LC-MS/MS method was developed for the quantification of swertiamarin (CAS 17388-39-5) in rat plasma and tissues using gentiopicroside as the internal standard (IS). Swertiamarin and an IS were extracted from plasma and tissues by a simple solid-phase extraction (SPE) procedure. Separation was achieved on a Phenomenex kinetex-C18 column (100 mm×2.1 mm, 2.6 µm) with an isocratic mobile phase consisting of methanol and water (22:78, v/v) with 0.1% acetic acid at a flow rate of 0.2 mL/min. The analyte and IS were detected by negative ion electrospray ionisation in multiple-reaction monitoring mode while monitoring the transitions of m/z 433 [M + CH3COO] − →179 and m/z 415 [M + CH3COO] − →179 for swertiamarin and the IS, respectively. The method was validated with respect to selectivity, matrix effect, linearity, accuracy, precision, recovery and stability. The method was successfully applied in a pharmacokinetic study of swertiamarin after intravenous and oral administration to rats. The pharmacokinetics of swertiamarin showed rapid absorption and elimination, and its absolute bioavailability was low at 10.3%. After oral administration to rats, swertiamarin was rapidly and widely distributed in its tissues. High concentrations were found in the liver and kidney, indicating that swertiamarin was possibly absorbed in the liver and eliminated by the kidney.
- 25 January 2012
- Published by Georg Thieme Verlag KG in Arzneimittelforschung
- Vol. 62 (03) , 138-144
Determination of the Plasma Pharmacokinetic and Tissue Distributions of Swertiamarin in Rats by Liquid Chromatography with Tandem Mass Spectrometry
An LC-MS/MS method was developed for the quantification of swertiamarin (CAS 17388-39-5) in rat plasma and tissues using gentiopicroside as the internal standard (IS). Swertiamarin and an IS were extracted from plasma and tissues by a simple solid-phase extraction (SPE) procedure. Separation was achieved on a Phenomenex kinetex-C18 column (100 mm×2.1 mm, 2.6 µm) with an isocratic mobile phase consisting of methanol and water (22:78, v/v) with 0.1% acetic acid at a flow rate of 0.2 mL/min. The analyte and IS were detected by negative ion electrospray ionisation in multiple-reaction monitoring mode while monitoring the transitions of m/z 433 [M + CH3COO] − →179 and m/z 415 [M + CH3COO] − →179 for swertiamarin and the IS, respectively. The method was validated with respect to selectivity, matrix effect, linearity, accuracy, precision, recovery and stability. The method was successfully applied in a pharmacokinetic study of swertiamarin after intravenous and oral administration to rats. The pharmacokinetics of swertiamarin showed rapid absorption and elimination, and its absolute bioavailability was low at 10.3%. After oral administration to rats, swertiamarin was rapidly and widely distributed in its tissues. High concentrations were found in the liver and kidney, indicating that swertiamarin was possibly absorbed in the liver and eliminated by the kidney.